via Mayo Clinic
Mayo Clinic researchers have uncovered stem cell-activated mechanisms of healing after a heart attack. Stem cells restored cardiac muscle back to its condition before the heart attack, in turn providing a blueprint of how stem cells may work.
The study, published in NPJ Regenerative Medicine, finds that human cardiopoietic cells zero in on damaged proteins to reverse complex changes caused by a heart attack. Cardiopoietic cells are derived from adult stem cell sources of bone marrow.
“The extent of change caused by a heart attack is too great for the heart to repair itself or to prevent further damage from occurring. Notably, however, cardiopoietic stem cell therapy reversed, either fully or partially, two-thirds of these disease-induced changes, such that 85% of all cellular functional categories affected by disease responded favorably to treatment,” says Andre Terzic, M.D., Ph.D., director of Mayo Clinic’s Center for Regenerative Medicine. Dr. Terzic is the senior author of the study.
This new understanding of how stem cells restore heart health could provide the framework for broader applications of stem cell therapy across various conditions.
“The actual mode of action of stem cells in repairing a diseased organ has until now been poorly understood, limiting adoption in clinical care. This study sheds light on the most intimate, yet comprehensive, regenerative mechanisms ? paving a road map for responsible and increasingly informed stem cell application,” says Dr. Terzic.
Heart disease is a leading cause of death in the U.S. Every 40 seconds, someone in the U.S. has a heart attack, according to the Centers for Disease Control and Prevention. During a heart attack, cardiac tissue dies, weakening the heart.
“The response of the diseased heart to cardiopoietic stem cell treatment revealed development and growth of new blood vessels, along with new heart tissue,” adds Kent Arrell, Ph.D., a Mayo Clinic cardiovascular researcher and first author of the study.
Researchers compared the diseased hearts of mice that did not receive human cardiopoietic stem cell therapy with those that did. Using a data science approach to map all the proteins in the heart muscle, researchers identified 4,000 cardiac proteins, more than 10% of which suffered damage by a heart attack.
“While we anticipated that the stem cell treatment would produce a beneficial outcome, we were surprised how far it shifted the state of diseased hearts away from disease and back toward a healthy, pre-disease state,” says Dr. Arrell.
Cardiopoietic stem cells are being tested in advanced clinical trials in heart patients.
“The current findings will enrich the base of knowledge pertinent to stem cell therapies and may have the potential to guide therapeutic regimens in the future,” says Dr. Terzic.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Stem cell therapies
- The effects of bone marrow stem and progenitor cell seeding on urinary bladder tissue regenerationon January 27, 2021 at 8:05 am
Complications associated with urinary bladder augmentation provide the motivation to delineate alternative bladder tissue regenerative engineering strategies. We describe the results of varying the ...
- Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparationson January 27, 2021 at 7:15 am
Clinical translation of pluripotent stem cell (PSC) derivatives is hindered by the tumorigenic risk from residual undifferentiated cells. Here, we identified salicylic diamines as potent agents ...
- Stem Cell Treatment Market Study 2020 With Top Companies, Technological Growth, Future Demand Analysis With Impact of COVID-19 Till 2027on January 27, 2021 at 2:18 am
Jan 27, 2021 (AmericaNewsHour) -- According to the latest market report published by Research Nester The global stem cell treatment market is segmented by stem cell type into embryonic cells, somatic ...
- Stem Cell Recruitment Therapy® Registration Awarded by U.S. Patent & Trademark Office for Russell Healthon January 26, 2021 at 7:45 pm
Based in Willowbrook, Illinois, Russell Health, a national marketer and distributor of specialty medical products and services, has ...
- Arthritis Drug Cuts GVHD Risk in Stem Cell Transplantson January 25, 2021 at 3:32 pm
A widely used arthritis drug reduced the rate of acute graft-versus-host disease (GVHD) in both HLA-matched and -mismatched allogeneic stem-cell transplants, a randomized study showed. The incidence ...
Go deeper with Google Headlines on:
Stem cell therapies
Go deeper with Bing News on:
Stem cells repair heart damage
- Stem Cells Market to Reach USD 17.78 Billion | Global Size Analysis, Segmentation, Industry Outlook, and Forecasts 2021-2027on January 20, 2021 at 3:19 am
Similarly, embryonic stem cell-derived cells may be used to replace tissues that have been damaged by injury or disease, including heart attacks, Parkinson’s disease, diabetes or spinal cord injury.
- Stem Cells in Cardiac Repairon January 18, 2021 at 4:00 pm
A population of resident cardiac stem cells ... identified from heart biopsies. The existence of each of these cell populations opens up additional opportunities for cardiac repair, especially ...
- Scientists closer to developing 'smart' stem cells made from human faton January 17, 2021 at 1:58 pm
Much controversy has surrounded stem cell research, and yet therapies and treatments involving stem cells have the capacity to treat a wide range of medical conditions. Stem cell therapy could be used ...
- Stem Cells in Cardiac Repairon January 16, 2021 at 4:00 pm
Although different stem ... reach the heart, many stem cells become lodged in the lungs. Consequently, with intravenous injections, the number of stem cells required for cardiac repair can be ...
- Scientists are a step closer to developing 'smart' stem cells – and they're made from human faton January 14, 2021 at 3:33 pm
"The stem cells we've developed can adapt to their surroundings and repair a range of damaged ... mend anything from traumatic injuries to heart damage. "This is one step further in the field ...